1 |
Chernyshova IA, Zakharenko AL, Kurochkin NN, Dyrkheeva NS, Kornienko TE, Popova NA, Nikolin VP, Ilina ES, Zharkov TD, Kupryushkin MS, Oslovsky VE, Drenichev MS, Lavrik OI. The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo. Molecules 2022;28. [PMID: 36615517 DOI: 10.3390/molecules28010323] [Reference Citation Analysis]
|
2 |
Pavlova VV, Zadorozhnii PV, Kiselev VV, Kharchenko AV. Synthesis, Spectral Characteristics, and Molecular Docking Studies of 2,4-Dichloro-N-(2,2,2-trichloro-1-((5-(phenylamino)-1,3,4-thiadiazol-2-yl)amino)ethyl)benzamide. ECSOC 2022 2022. [DOI: 10.3390/ecsoc-26-13642] [Reference Citation Analysis]
|
3 |
Ivankin DI, Dyrkheeva NS, Zakharenko AL, Ilina ES, Zarkov TO, Reynisson J, Luzina OA, Volcho KP, Salakhutdinov NF, Lavrik OI. Monoterpene substituted thiazolidin-4-ones as novel TDP1 inhibitors: synthesis, biological evaluation and docking. Bioorg Med Chem Lett 2022;:128909. [PMID: 35907608 DOI: 10.1016/j.bmcl.2022.128909] [Reference Citation Analysis]
|